Ariella Kelman is Senior Vice President of Clinical Development at HI-Bio. Prior to joining HI-Bio, she worked at Genentech and Roche in roles that included Global Development Leader for Rituxan Immunology, Senior Group Medical Director for Actemra and Global Head of Bioethics. Ariella was also an attending physician in the Stanford Division of Immunology and Rheumatology for 10 years.
She received her BS from UCLA, MD from Tel Aviv University and a Graduate Certificate in Bioethics from Columbia University. Her training included Internal Medicine Residency at Kaiser Permanente Medical Center in Santa Clara and Fellowship in Rheumatology at the Stanford University Hospital.